← 產業報告目錄

Patient Monitoring Devices Market By Product (Multiparameter, Glucose CGM, Wearables, EEG, EMG, ECG, ILR, MCT, Pulse Oximeter, Fetal, Neonatal, BP, Hemodynamic, Spirometer, Capnograph), End User (Hospital, ICU, ASC), & Region - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-06-12頁數 453報告編號 MD2436

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The patient monitoring devices market is projected to reach USD 76.11 billion by 2031, up from USD 55.60 billion in 2026, at a CAGR of 6.4%. Continuous technological innovation and increasing adoption of connected healthcare technologies are significantly driving growth in the patient monitoring devices market. Advancements in patient monitoring systems, including wearable devices, continuous glucose monitoring (CGM), remote patient monitoring platforms, and AI-enabled analytics, offer real-time health tracking, improved clinical decision-making, and enhanced patient outcomes. These technologies support continuous monitoring, reduce dependence on hospitals, and enable early detection of health deterioration. Additionally, innovations in device design have led to compact, wireless, and user-friendly systems, making them more suitable for hospital and home-care settings. Manufacturers are increasingly integrating smart features such as cloud connectivity, mobile applications, predictive analytics, and telehealth compatibility. This ongoing innovation cycle is accelerating the replacement of traditional monitoring systems and driving sustained global demand for advanced patient monitoring devices. Based on product: The patient monitoring devices market includes multiparameter monitors, blood glucose monitoring devices (CGM and SMBG), wearable monitoring devices, EEG, EMG, ICP, ECG, ILR, MCT, pulse oximeters, fetal & neonatal monitors, blood pressure monitoring devices, hemodynamic monitoring systems, spirometers, and capnography devices. Among these, blood glucose monitoring devices, particularly continuous glucose monitoring (CGM) systems, represent a major growth-driving subsegment. The dominance of this segment is driven primarily by the rising global prevalence of diabetes and the growing need for continuous disease management. CGM and wearable glucose monitoring devices provide real-time glucose insights that support timely treatment decisions and improve patient outcomes. Strong adoption across hospitals, clinics, and home care settings, coupled with rising demand for preventive healthcare, home-based monitoring, smartphone connectivity, and connected healthcare platforms, continues to strengthen the market position of blood glucose monitoring devices. Based on end user: Hospitals and clinics account for the largest share of the patient monitoring devices market due to their central role in managing acute and chronic conditions requiring continuous patient surveillance. These facilities routinely utilize patient monitoring systems across general wards, intensive care units (ICUs), and emergency & trauma centers to track critical parameters such as heart rate, blood pressure, oxygen saturation, and glucose levels. The growing prevalence of cardiovascular diseases, diabetes, and respiratory disorders has significantly increased demand for real-time monitoring and early clinical intervention. Additionally, hospitals and clinics benefit from advanced healthcare infrastructure, skilled professionals, and integration of connected monitoring technologies. Ongoing investments in critical care capabilities and digital healthcare solutions further drive the adoption of patient monitoring devices, reinforcing the dominance of hospitals and clinics in the market. North America’s well-developed healthcare infrastructure plays a crucial role in supporting the widespread adoption of patient monitoring devices. The region has an extensive network of hospitals, specialty clinics, and advanced care facilities equipped with modern monitoring technologies to efficiently manage acute and chronic conditions. Healthcare systems across the US and Canada are characterized by strong clinical protocols, high healthcare spending, and highly trained professionals, enabling seamless integration of patient monitoring solutions into routine care. Additionally, the growing adoption of continuous glucose monitoring systems, cardiac monitoring devices, wearable technologies, and remote patient monitoring platforms supports early diagnosis and timely intervention. Regular investments in digital health technologies and continuous upgrades of monitoring systems further contribute to sustained demand. The presence of a robust healthcare ecosystem ensures consistent utilization and adoption of patient monitoring devices across multiple care settings. A breakdown of the primary respondents (supply-side) for the patient monitoring devices market referred to in this report is provided below: • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30% • By Designation: C-level: 55%, Director Level: 27%, and Others: 18% • By Region: North America: 34%, Europe: 27%, Asia Pacific: 30%, Latin America: 6%, Middle East & Africa: 2% and GCC Countries: 2% Prominent players in the patient monitoring devices market include Medtronic Plc (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Masimo Corporation (US), Omron Corporation (Japan), ARCHIMED SAS (Natus Medical) (France), Compumedics Limited (Australia), and Nonin Medical, Inc. (US), among others. Research Coverage The report evaluates the patient monitoring devices market and estimates the market size and future growth potential of this market based on various segments, including product, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will assist market leaders and new entrants in the patient monitoring devices market with data on the nearest approximations of revenue figures for the overall market and its subsegments. The report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. It also enables stakeholders to understand market dynamics and provides insights into key drivers, restraints, challenges, and growth opportunities influencing the patient monitoring devices market. This report provides insights into the following points: • Analysis of key drivers (rising prevalence of chronic diseases such as diabetes and cardiovascular disorders, growing aging population requiring continuous monitoring and long-term healthcare management, increasing demand for remote patient monitoring and home healthcare solutions, rapid adoption of wearable and connected healthcare technologies, technological advancements in AI-enabled and cloud-integrated monitoring systems), restraints (high cost of advanced monitoring systems, data privacy and cybersecurity concerns, stringent regulatory approval requirements for medical devices), opportunities (expansion of remote patient monitoring platforms, development of low-cost and portable monitoring devices, growing adoption of home-based and preventive healthcare solutions), and challenges (limited healthcare infrastructure in developing regions, interoperability issues across connected monitoring platforms, reimbursement and adoption barriers in emerging markets) • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global patient monitoring devices market. • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, end user, and region. • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global patient monitoring devices market • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global patient monitoring devices market
目錄 Table of Contents
1 INTRODUCTION 36 1.1 STUDY OBJECTIVES 36 1.2 MARKET DEFINITION 36 1.3 STUDY SCOPE 37 1.3.1 MARKETS COVERED 37 1.3.2 INCLUSIONS AND EXCLUSIONS 38 1.3.3 YEARS CONSIDERED 38 1.3.4 CURRENCY CONSIDERED 39 1.4 STAKEHOLDERS 39 1.5 SUMMARY OF CHANGES 40 2 EXECUTIVE SUMMARY 41 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 41 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS 43 2.3 DISRUPTIVE TRENDS SHAPING MARKET 44 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 45 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 46 3 PREMIUM INSIGHTS 47 3.1 PATIENT MONITORING DEVICES MARKET OVERVIEW 47 3.2 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT AND COUNTRY (2025) 48 3.3 PATIENT MONITORING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49 3.4 PATIENT MONITORING DEVICES MARKET, BY REGION (2024–2031) 50 3.5 PATIENT MONITORING DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 50 4 MARKET OVERVIEW 51 4.1 INTRODUCTION 51 4.2 MARKET DYNAMICS 51 4.2.1 DRIVERS 52 4.2.1.1 Emergence of predictive analytics in vital sign monitors 52 4.2.1.2 Growing preference for wearable patient monitoring devices, biosensors, and smart implants 53 4.2.1.3 Availability of wireless monitoring devices 53 4.2.1.4 Expansion of telehealth services and remote monitoring capabilities 54 4.2.1.5 Growing incidence of chronic diseases 54   4.2.2 RESTRAINTS 56 4.2.2.1 Risks associated with invasive monitoring devices 56 4.2.2.2 High cost of patient monitoring products and inadequate reimbursement 56 4.2.3 OPPORTUNITIES 57 4.2.3.1 Integration with electronic health records (EHRs) 57 4.2.3.2 Expansion of remote patient monitoring in home healthcare settings 58 4.2.4 CHALLENGES 58 4.2.4.1 Lack of personnel and limited awareness & education for patient monitoring devices 58 4.2.4.2 Increased pricing pressure on market players 59 4.3 UNMET NEEDS AND WHITE SPACES 60 4.3.1 UNMET NEEDS IN PATIENT MONITORING DEVICES MARKET 60 4.3.2 WHITE SPACE OPPORTUNITIES 61 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 62 4.4.1 INTERCONNECTED MARKETS 62 4.4.2 CROSS-SECTOR OPPORTUNITIES 62 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63 5 INDUSTRY TRENDS 64 5.1 PORTER’S FIVE FORCES ANALYSIS 64 5.1.1 THREAT OF NEW ENTRANTS 65 5.1.2 THREAT OF SUBSTITUTES 65 5.1.3 BARGAINING POWER OF SUPPLIERS 66 5.1.4 BARGAINING POWER OF BUYERS 66 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 66 5.2 MACROECONOMIC OUTLOOK 66 5.2.1 INTRODUCTION 66 5.2.2 GDP TRENDS AND FORECAST 66 5.2.3 TRENDS IN GLOBAL PATIENT MONITORING DEVICES INDUSTRY 68 5.2.4 TRENDS IN GLOBAL HEALTHCARE & MEDICAL DEVICES INDUSTRY 68 5.3 SUPPLY CHAIN ANALYSIS 69 5.3.1 PROMINENT COMPANIES 69 5.3.2 SMALL & MEDIUM-SIZED COMPANIES 69 5.3.3 END USERS 69 5.4 VALUE CHAIN ANALYSIS 70 5.4.1 RESEARCH & DEVELOPMENT 70 5.4.2 PROCUREMENT AND PRODUCT DEVELOPMENT 70 5.4.3 MARKETING, SALES, DISTRIBUTION, AND POST-SALES SERVICES 70 5.5 ECOSYSTEM ANALYSIS 71 5.6 PRICING ANALYSIS 72 5.6.1 AVERAGE SELLING PRICE, BY PRODUCT (2025) 72 5.6.2 AVERAGE SELLING PRICE, BY REGION (2025) 73 5.7 TRADE ANALYSIS 75 5.7.1 IMPORT SCENARIO (HS CODE 9018) 76 5.7.2 EXPORT DATA (HS CODE 9018) 76 5.8 KEY CONFERENCES AND EVENTS, 2026–2027 77 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78 5.10 INVESTMENT AND FUNDING SCENARIO 79 5.11 CASE STUDY ANALYSIS 79 5.11.1 CASE STUDY 1: SCALING REMOTE CARDIAC MONITORING 79 5.11.2 CASE STUDY 2: IMPROVING CHRONIC DISEASE MANAGEMENT THROUGH RPM 80 5.11.3 CASE STUDY 3: ENHANCING PATIENT SURVEILLANCE IN ACUTE CARE SETTINGS 80 5.12 IMPACT OF US TARIFFS—PATIENT MONITORING DEVICES MARKET 80 5.12.1 INTRODUCTION 80 5.12.2 KEY TARIFF RATES 81 5.12.3 PRICE IMPACT ANALYSIS 82 5.12.4 IMPACT ON COUNTRIES/REGIONS 83 5.12.4.1 North America 83 5.12.4.2 Europe 83 5.12.4.3 Asia Pacific 83 5.12.5 IMPACT ON END-USE INDUSTRIES 83 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 85 6.1 KEY EMERGING TECHNOLOGIES 85 6.1.1 SMART WEARABLE MONITORING DEVICES 85 6.1.2 VITAL SIGN MONITORS 85 6.2 COMPLEMENTARY TECHNOLOGIES 86 6.2.1 REMOTE PATIENT MONITORS 86 6.2.2 AI & IOT 86 6.3 TECHNOLOGY/PRODUCT ROADMAP 87 6.3.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 87 6.3.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 87 6.3.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 88 6.4 PATENT ANALYSIS 89 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 90 6.5 FUTURE APPLICATIONS 90 6.5.1 AI-ENABLED REMOTE PATIENT MONITORING & PREDICTIVE HEALTH ANALYTICS 91 6.5.2 HOME-BASED CHRONIC DISEASE MANAGEMENT & TELEHEALTH INTEGRATION 91 6.5.3 SMART HOSPITALS & INTEGRATED CLINICAL MONITORING NETWORKS 91   6.6 IMPACT OF AI/GEN AI ON PATIENT MONITORING DEVICES MARKET 92 6.6.1 TOP USE CASES AND MARKET POTENTIAL 92 6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN PATIENT MONITORING DEVICES MARKET 93 6.6.3 INTERCONNECTED/ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 93 6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PATIENT MONITORING DEVICES MARKET 94 7 REGULATORY LANDSCAPE 95 7.1 REGIONAL REGULATIONS AND COMPLIANCE 95 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 7.1.2 INDUSTRY STANDARDS 99 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 100 8.1 DECISION-MAKING PROCESS 100 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 100 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 100 8.2.2 KEY BUYING CRITERIA 101 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 102 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 102 8.5 MARKET PROFITABILITY 103 8.5.1 REVENUE POTENTIAL 103 8.5.2 COST DYNAMICS 103 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 104 9 PATIENT MONITORING DEVICES MARKET, BY PRODUCT 105 9.1 INTRODUCTION 106 9.2 BLOOD GLUCOSE MONITORING DEVICES 107 9.2.1 SELF-MONITORING BLOOD GLUCOSE DEVICES 108 9.2.1.1 Rising adoption of integrated glucose monitoring devices to drive growth 108 9.2.2 CONTINUOUS GLUCOSE MONITORING DEVICES 110 9.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth 110 9.2.3 WEARABLE GLUCOSE MONITORING DEVICES 112 9.2.3.1 Growing patient inclination towards wearable monitors to boost the market 112 9.3 CARDIAC MONITORING DEVICES 113 9.3.1 ECG DEVICES 115 9.3.1.1 Low cost and wide applications of ECG devices to drive market growth 115 9.3.2 IMPLANTABLE LOOP RECORDERS 117 9.3.2.1 High cost and limited applications to limit growth 117 9.3.3 EVENT MONITORS 118 9.3.3.1 Emergence of portable and wireless event monitors to drive market growth 118 9.3.4 MCT MONITORS 119 9.3.4.1 Availability of alternate technologies to hinder market growth 119 9.3.5 SMART/WEARABLE ECG MONITORS 121 9.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors 121 9.4 MULTIPARAMETER MONITORING DEVICES 123 9.4.1 LOW-ACUITY MONITORS 125 9.4.1.1 Increasing adoption of low-acuity monitors in general wards to drive market growth 125 9.4.2 MID-ACUITY MONITORS 126 9.4.2.1 Rising geriatric population to increase market growth 126 9.4.3 HIGH-ACUITY MONITORS 127 9.4.3.1 Increasing partnerships between manufacturers and hospitals & clinics to drive device sales 127 9.5 RESPIRATORY MONITORING DEVICES 128 9.5.1 PULSE OXIMETERS 130 9.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth 130 9.5.2 SPIROMETERS 131 9.5.2.1 Technological advancements to increase adoption of spirometers 131 9.5.3 CAPNOGRAPHS 133 9.5.3.1 Product development and growing commercial acceptance to drive market growth 133 9.5.4 PEAK FLOW METERS 134 9.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices, to hinder market growth 134 9.6 TEMPERATURE MONITORING DEVICES 136 9.6.1 HANDHELD TEMPERATURE MONITORING DEVICES 137 9.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth 137 9.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES 139 9.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices 139 9.6.3 WEARABLE CONTINUOUS MONITORING DEVICES 141 9.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand 141 9.6.4 INVASIVE TEMPERATURE MONITORING DEVICES 142 9.6.4.1 Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices 142 9.6.5 SMART TEMPERATURE MONITORING PATCHES 144 9.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth 144   9.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES 146 9.7.1 HEMODYNAMIC MONITORS 147 9.7.1.1 Influx of VC funding to drive market growth 147 9.7.2 BLOOD PRESSURE MONITORS 149 9.7.2.1 Development of wearable blood pressure monitors to drive market growth 149 9.7.3 DISPOSABLES 150 9.7.3.1 Growing number of surgical procedures to drive growth in disposables market 150 9.8 FETAL & NEONATAL MONITORING DEVICES 151 9.8.1 FETAL MONITORING DEVICES 153 9.8.1.1 Rising prevalence of obstetric complications to drive market growth 153 9.8.2 NEONATAL MONITORING DEVICES 155 9.8.2.1 Rising number of neonatal care facilities worldwide to drive market 155 9.9 NEUROMONITORING DEVICES 157 9.9.1 EEG MACHINES 158 9.9.1.1 Growing applications and technological advancements to favor market growth 158 9.9.2 EMG MACHINES 160 9.9.2.1 Availability of reimbursements for EMG-assisted surgeries to boost product demand 160 9.9.3 CEREBRAL OXIMETERS 161 9.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth 161 9.9.4 ICP MONITORS 163 9.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors 163 9.9.5 MEG MACHINES 164 9.9.5.1 High implementation and maintenance costs of MEG devices hinder market growth 164 9.9.6 TCD MACHINES 165 9.9.6.1 Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth 165 9.10 WEIGHT MONITORING DEVICES 167 9.10.1 DIGITAL WEIGHT MONITORING DEVICES 168 9.10.1.1 Consumer preference for digital scales—a key market driver 168 9.10.2 ANALOG WEIGHT MONITORING DEVICES 170 9.10.2.1 Rising prevalence of obesity and low cost of analog scales to support market growth 170 9.11 OTHER PATIENT MONITORING DEVICES 171   10 PATIENT MONITORING DEVICES MARKET, BY END USER 174 10.1 INTRODUCTION 175 10.2 HOSPITALS & CLINICS 175 10.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET 175 10.3 AMBULATORY SURGICAL CENTERS 177 10.3.1 COST-EFFECTIVENESS AND CONVENIENCE TO DRIVE DEMAND FOR AMBULATORY CARE 177 10.4 HOME CARE SETTINGS 178 10.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH 178 10.5 OTHER END USERS 179 11 PATIENT MONITORING DEVICES MARKET, BY REGION 181 11.1 INTRODUCTION 182 11.2 NORTH AMERICA 183 11.2.1 US 189 11.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth 189 11.2.2 CANADA 196 11.2.2.1 Growing public-private funding for research to drive market growth 196 11.3 EUROPE 204 11.3.1 GERMANY 210 11.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth 210 11.3.2 UK 216 11.3.2.1 Increasing public & private investments to contribute to market growth 216 11.3.3 FRANCE 222 11.3.3.1 Statutory health insurance system to support market growth 222 11.3.4 ITALY 228 11.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices 228 11.3.5 SPAIN 234 11.3.5.1 Growing number of surgical procedures to drive market growth in Spain 234 11.3.6 REST OF EUROPE 240 11.4 ASIA PACIFIC 246 11.4.1 JAPAN 253 11.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth 253 11.4.2 CHINA 259 11.4.2.1 Growing focus of local and international market players to favor market growth 259   11.4.3 INDIA 265 11.4.3.1 Increasing government-implemented healthcare initiatives to support market growth 265 11.4.4 AUSTRALIA 271 11.4.4.1 R&D tax incentive program to support market growth 271 11.4.5 SOUTH KOREA 277 11.4.5.1 Supportive government initiatives to drive market growth 277 11.4.6 REST OF ASIA PACIFIC 283 11.5 LATIN AMERICA 290 11.5.1 BRAZIL 296 11.5.1.1 Brazil to dominate LATAM market 296 11.5.2 MEXICO 302 11.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 302 11.5.3 REST OF LATIN AMERICA 308 11.6 MIDDLE EAST & AFRICA 315 11.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES 315 11.7 GCC COUNTRIES 321 11.7.1 HEALTHCARE DIGITALIZATION INITIATIVES TO ACCELERATE PATIENT MONITORING DEVICE ADOPTION IN GCC 321 12 COMPETITIVE LANDSCAPE 328 12.1 OVERVIEW 328 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 328 12.3 REVENUE ANALYSIS 329 12.4 MARKET SHARE ANALYSIS 330 12.4.1 GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025 330 12.4.2 GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025 331 12.4.3 GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025 332 12.4.4 GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025 332 12.4.5 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025 333 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 335 12.5.1 STARS 335 12.5.2 EMERGING LEADERS 335 12.5.3 PERVASIVE PLAYERS 335 12.5.4 PARTICIPANTS 335 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 337 12.5.5.1 Company footprint 337 12.5.5.2 Region footprint 338 12.5.5.3 Product footprint 339 12.5.5.4 End-user footprint 340 12.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025 341 12.6.1 PROGRESSIVE COMPANIES 341 12.6.2 RESPONSIVE COMPANIES 341 12.6.3 DYNAMIC COMPANIES 341 12.6.4 STARTING BLOCKS 341 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 343 12.6.5.1 Detailed list of key startups/SMEs 343 12.6.5.2 Competitive benchmarking of key startups/SMEs, 2025 344 12.7 COMPANY VALUATION & FINANCIAL METRICS 345 12.8 BRAND/PRODUCT COMPARISON 346 12.9 COMPETITIVE SCENARIO 347 12.9.1 PRODUCT LAUNCHES & APPROVALS 347 12.9.2 DEALS 347 12.9.3 EXPANSIONS 348 13 COMPANY PROFILES 349 13.1 KEY PLAYERS 349 13.1.1 MEDTRONIC 349 13.1.1.1 Business overview 349 13.1.1.2 Products offered 350 13.1.1.3 Recent developments 353 13.1.1.3.1 Product launches & approvals 353 13.1.1.3.2 Deals 354 13.1.1.4 MnM view 355 13.1.1.4.1 Right to win 355 13.1.1.4.2 Strategic choices 355 13.1.1.4.3 Weaknesses and competitive threats 355 13.1.2 ABBOTT LABORATORIES 356 13.1.2.1 Business overview 356 13.1.2.2 Products offered 357 13.1.2.3 Recent developments 358 13.1.2.3.1 Product launches & approvals 358 13.1.2.3.2 Deals 360 13.1.2.4 MnM view 360 13.1.2.4.1 Right to win 360 13.1.2.4.2 Strategic choices 360 13.1.2.4.3 Weaknesses & competitive threats 361   13.1.3 DEXCOM, INC. 362 13.1.3.1 Business overview 362 13.1.3.2 Products offered 363 13.1.3.3 Recent developments 364 13.1.3.3.1 Product launches & approvals 364 13.1.3.3.2 Deals 364 13.1.3.4 MnM view 365 13.1.3.4.1 Right to win 365 13.1.3.4.2 Strategic choices 365 13.1.3.4.3 Weaknesses & competitive threats 365 13.1.4 GE HEALTHCARE 366 13.1.4.1 Business overview 366 13.1.4.2 Products offered 367 13.1.4.3 Recent developments 369 13.1.4.3.1 Product launches & approvals 369 13.1.4.3.2 Deals 369 13.1.4.4 MnM view 370 13.1.4.4.1 Right to win 370 13.1.4.4.2 Strategic choices 370 13.1.4.4.3 Weaknesses & competitive threats 370 13.1.5 PHILIPS HEALTHCARE 371 13.1.5.1 Business overview 371 13.1.5.2 Products offered 372 13.1.5.3 Recent developments 375 13.1.5.3.1 Product launches & approvals 375 13.1.5.3.2 Deals 375 13.1.5.4 MnM view 377 13.1.5.4.1 Right to win 377 13.1.5.4.2 Strategic choices 377 13.1.5.4.3 Weaknesses & competitive threats 377 13.1.6 NIHON KOHDEN CORPORATION 378 13.1.6.1 Business overview 378 13.1.6.2 Products offered 379 13.1.6.3 Recent developments 381 13.1.6.3.1 Product launches & approvals 381 13.1.6.3.2 Deals 381 13.1.7 MINDRAY MEDICAL INTERNATIONAL LTD. 383 13.1.7.1 Business overview 383 13.1.7.2 Products offered 384 13.1.7.3 Recent developments 385 13.1.7.3.1 Product launches & approvals 385 13.1.7.3.2 Deals 386 13.1.8 BD 387 13.1.8.1 Business overview 387 13.1.8.2 Products offered 388 13.1.9 GETINGE AB 390 13.1.9.1 Business overview 390 13.1.9.2 Products offered 391 13.1.9.3 Recent developments 392 13.1.9.3.1 Product launches, enhancements, and approvals 392 13.1.9.3.2 Deals 393 13.1.10 BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.) 394 13.1.10.1 Business overview 394 13.1.10.2 Products offered 395 13.1.11 DRÄGERWERK AG & CO. KGAA 398 13.1.11.1 Business overview 398 13.1.11.2 Products offered 399 13.1.12 BOSTON SCIENTIFIC CORPORATION 402 13.1.12.1 Business overview 402 13.1.12.2 Products offered 403 13.1.12.3 Recent developments 404 13.1.12.3.1 Deals 404 13.1.13 MASIMO CORPORATION 405 13.1.13.1 Business overview 405 13.1.13.2 Products offered 406 13.1.14 OMRON CORPORATION 410 13.1.14.1 Business overview 410 13.1.14.2 Products offered 411 13.1.15 ARCHIMED SAS (NATUS MEDICAL) 415 13.1.15.1 Business overview 415 13.1.15.2 Products offered 415 13.1.15.3 Recent developments 416 13.1.15.3.1 Deals 416 13.1.16 COMPUMEDICS LIMITED 417 13.1.16.1 Business overview 417 13.1.16.2 Products offered 418 13.1.16.3 Recent developments 419 13.1.16.3.1 Deals 419 13.1.17 NONIN MEDICAL, INC. 420 13.1.17.1 Business overview 420 13.1.17.2 Products offered 420 13.1.17.3 Recent developments 421 13.1.17.3.1 Product launches & approvals 421   13.2 OTHER PLAYERS 422 13.2.1 BIOTRONIK 422 13.2.2 SCHILLER AG 422 13.2.3 SENSEONICS 424 13.2.4 CARDIOMO 424 13.2.5 VITLS 425 13.2.6 NETEERA 425 13.2.7 QARDIO 426 13.2.8 VIVIFY HEALTH 426 13.2.9 IRHYTHM TECHNOLOGIES, INC. 427 13.2.10 OSYPKA MEDICAL 427 13.2.11 CARDINAL HEALTH 428 13.2.12 MERIT MEDICAL SYSTEMS 429 14 RESEARCH METHODOLOGY 430 14.1 RESEARCH DATA 430 14.1.1 SECONDARY DATA 431 14.1.1.1 Key data from secondary sources 432 14.1.2 PRIMARY DATA 433 14.1.2.1 Key data from primary sources 434 14.1.2.2 Key industry insights 434 14.2 MARKET SIZE ESTIMATION 436 14.3 MARKET BREAKDOWN AND DATA TRIANGULATION 441 14.4 MARKET SHARE ESTIMATION 442 14.5 STUDY ASSUMPTIONS 442 14.6 METHODOLOGY-RELATED LIMITATIONS 442 14.7 RESEARCH LIMITATIONS 442 14.8 RISK ASSESSMENT 443 15 APPENDIX 444 15.1 DISCUSSION GUIDE 444 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 449 15.3 CUSTOMIZATION OPTIONS 451 15.4 RELATED REPORTS 451 15.5 AUTHOR DETAILS 452
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES TO USD 39 TABLE 2 PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS 64 TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030 67 TABLE 4 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY KEY PLAYER, 2025 (USD) 73 TABLE 5 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY REGION, 2025 (USD) 74 TABLE 6 IMPORT DATA FOR PATIENT MONITORING DEVICES PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 76 TABLE 7 EXPORT DATA FOR PATIENT MONITORING DEVICES UNDER HS CODE 9018, BY COUNTRY, 2021–2025 (USD THOUSAND) 77 TABLE 8 PATIENT MONITORING DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026-2027) 77 TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES 81 TABLE 10 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR PATIENT MONITORING DEVICES 82 TABLE 11 TOP USE CASES AND MARKET POTENTIAL 92 TABLE 12 PATIENT MONITORING DEVICES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 93 TABLE 13 INTERCONNECTED/ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 93 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 19 GLOBAL STANDARDS IN PATIENT MONITORING DEVICES MARKET 99 TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES 101 TABLE 21 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES 102 TABLE 22 PATIENT MONITORING DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 102 TABLE 23 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 106 TABLE 24 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 107 TABLE 25 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 107 TABLE 26 PATIENT MONITORING DEVICES MARKET VOLUME FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 108 TABLE 27 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 28 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 29 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 112 TABLE 30 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 113 TABLE 31 CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 32 PATIENT MONITORING DEVICES MARKET VOLUME FOR CARDIAC MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 115 TABLE 33 ECG DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 116 TABLE 34 IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 35 EVENT MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 36 MCT MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 37 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS 121 TABLE 38 SMART/WEARABLE ECG MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 39 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 123 TABLE 40 MULTIPARAMETER MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 124 TABLE 41 PATIENT MONITORING DEVICES MARKET VOLUME FOR MULTI-PARAMETER MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 125 TABLE 42 LOW-ACUITY MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 43 MID-ACUITY MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 44 HIGH-ACUITY MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 45 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 128 TABLE 46 RESPIRATORY MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 47 PATIENT MONITORING DEVICES MARKET VOLUME FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 130 TABLE 48 PULSE OXIMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 49 SPIROMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 50 CAPNOGRAPHS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 51 PEAK FLOW METERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 52 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 53 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 54 PATIENT MONITORING DEVICES MARKET VOLUME FOR TEMPERATURE MONITORING SYSTEMS, BY REGION, 2024–2031 (UNITS) 137 TABLE 55 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS 138 TABLE 56 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 57 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 58 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS 141 TABLE 59 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 60 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 61 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS 144 TABLE 62 SMART TEMPERATURE MONITORING PATCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 63 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 64 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 65 PATIENT MONITORING DEVICES MARKET VOLUME FOR HEMODYNAMIC/ PRESSURE MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 147 TABLE 66 HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 67 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS 149 TABLE 68 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 69 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 70 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 71 FETAL & NEONATAL MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 72 PATIENT MONITORING DEVICES MARKET VOLUME FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 153 TABLE 73 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS 154 TABLE 74 FETAL MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 75 NEONATAL MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 76 NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 157 TABLE 77 NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 78 PATIENT MONITORING DEVICES MARKET VOLUME FOR NEUROMONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 158 TABLE 79 EEG MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 80 EMG MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 81 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 82 ICP MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 83 MEG MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 84 TCD MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 85 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 167 TABLE 86 WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 87 PATIENT MONITORING DEVICES MARKET VOLUME FOR WEIGHT MONITORING DEVICES, BY REGION, 2024–2031 (UNITS) 168 TABLE 88 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 89 ANALOG WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 90 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS 171 TABLE 91 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS 172 TABLE 92 OTHER PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 93 PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 175 TABLE 94 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2024–2031 (USD MILLION) 176 TABLE 95 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 96 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 97 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 98 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 99 PATIENT MONITORING DEVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 100 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 101 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184 TABLE 102 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 103 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 104 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 186 TABLE 105 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 186 TABLE 106 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 107 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 108 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 188 TABLE 109 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 188 TABLE 110 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 111 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 189 TABLE 112 US: VC FUNDING IN PATIENT MONITORING DEVICES MARKET 190 TABLE 113 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 191 TABLE 114 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 115 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 116 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 117 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 118 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 119 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 120 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 121 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 122 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 123 US: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 196 TABLE 124 RESEARCH GRANTS IN PATIENT MONITORING DEVICES MARKET IN CANADA 197 TABLE 125 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING DEVICES MARKET 197 TABLE 126 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 198 TABLE 127 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 128 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 129 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 130 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 131 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 132 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 133 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 134 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 135 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 136 CANADA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 203 TABLE 137 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING DEVICES MARKET 204 TABLE 138 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 139 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 205 TABLE 140 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 141 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 142 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 143 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 144 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 145 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 146 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 147 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 148 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 149 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 210 TABLE 150 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 211 TABLE 151 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 152 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 153 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 154 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 155 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 156 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 157 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 158 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 159 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 160 GERMANY: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 216 TABLE 161 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 217 TABLE 162 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 163 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 164 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 165 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 166 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 167 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 168 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 169 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 170 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 171 UK: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 222 TABLE 172 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 223 TABLE 173 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 174 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 175 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 176 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 177 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 178 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 179 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 180 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 181 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 182 FRANCE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 228 TABLE 183 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 229 TABLE 184 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 185 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 230 TABLE 186 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 230 TABLE 187 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 188 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 189 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 190 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 191 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 192 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 193 ITALY: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 234 TABLE 194 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 235 TABLE 195 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 196 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 197 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 198 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 199 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 200 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 201 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 202 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 203 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 204 SPAIN: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 240 TABLE 205 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 241 TABLE 206 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 207 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 208 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 209 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 210 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 211 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 212 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 213 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 214 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 215 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 246 TABLE 216 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 217 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 248 TABLE 218 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 219 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 220 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 221 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 222 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 223 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 224 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 225 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 226 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 227 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 253 TABLE 228 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 254 TABLE 229 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 230 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 231 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 232 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 233 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 234 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 235 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 236 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 237 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 238 JAPAN: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 259 TABLE 239 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 260 TABLE 240 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 241 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 242 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 243 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 244 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 245 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 246 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 247 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 248 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 249 CHINA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 265 TABLE 250 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 266 TABLE 251 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 252 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 253 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 254 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 255 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 256 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 257 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 258 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 259 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 260 INDIA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 271 TABLE 261 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 272 TABLE 262 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 263 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 264 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 265 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 266 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 267 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 268 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 269 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 270 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 271 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 277 TABLE 272 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 278 TABLE 273 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 274 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 275 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 276 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 277 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 278 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 279 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 280 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 281 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 282 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 283 TABLE 283 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 284 TABLE 284 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 285 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 286 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 287 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 288 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 289 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 290 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 291 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 292 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 293 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 289 TABLE 294 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 295 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 291 TABLE 296 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 297 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 298 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 299 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 300 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 301 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 302 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 303 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 304 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 305 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 296 TABLE 306 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 297 TABLE 307 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 308 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 309 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 310 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 311 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 312 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 313 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 314 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 315 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 316 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 302 TABLE 317 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 303 TABLE 318 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 319 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 320 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 321 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 322 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 323 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 324 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 325 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 326 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 327 MEXICO: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 308 TABLE 328 REST OF LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 309 TABLE 329 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 330 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 331 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 332 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 333 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 334 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 335 REST OF LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 336 REST OF LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 337 REST OF LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 338 REST OF LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 314 TABLE 339 MIDDLE EAST & AFRICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 316 TABLE 340 MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 316 TABLE 341 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 342 MIDDLE EAST & AFRICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 343 MIDDLE EAST & AFRICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 344 MIDDLE EAST & AFRICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 345 MIDDLE EAST & AFRICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 346 MIDDLE EAST & AFRICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 347 MIDDLE EAST & AFRICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 348 MIDDLE EAST & AFRICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 349 MIDDLE EAST & AFRICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 321 TABLE 350 GCC COUNTRIES: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 322 TABLE 351 GCC COUNTRIES: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 352 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 353 GCC COUNTRIES: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 354 GCC COUNTRIES: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 355 GCC COUNTRIES: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 356 GCC COUNTRIES: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 357 GCC COUNTRIES: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 325 TABLE 358 GCC COUNTRIES: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 359 GCC COUNTRIES: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 326 TABLE 360 GCC COUNTRIES: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 327 TABLE 361 KEY DEVELOPMENTS IN PATIENT MONITORING DEVICES MARKET, JANUARY 2022–JUNE 2026 328 TABLE 362 PATIENT MONITORING MARKET: DEGREE OF COMPETITION 334 TABLE 363 PATIENT MONITORING DEVICES MARKET: REGION FOOTPRINT (17 COMPANIES) 338 TABLE 364 PATIENT MONITORING DEVICES MARKET: PRODUCT FOOTPRINT (17 COMPANIES) 339 TABLE 365 PATIENT MONITORING DEVICES MARKET: END-USER FOOTPRINT (17 COMPANIES) 340 TABLE 366 PATIENT MONITORING DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 343 TABLE 367 PATIENT MONITORING DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, 2025 344 TABLE 368 PATIENT MONITORING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JANUARY 2026 347 TABLE 369 PATIENT MONITORING DEVICES MARKET: DEALS, JANUARY 2022–JANUARY 2026 347 TABLE 370 PATIENT MONITORING DEVICES MARKET: EXPANSIONS, JANUARY 2022–JANUARY 2026 348 TABLE 371 MEDTRONIC: COMPANY OVERVIEW 349 TABLE 372 MEDTRONIC PLC: PRODUCTS OFFERED 350 TABLE 373 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS 353 TABLE 374 MEDTRONIC PLC: DEALS 354 TABLE 375 ABBOTT LABORATORIES: COMPANY OVERVIEW 356 TABLE 376 ABBOTT LABORATORIES: PRODUCTS OFFERED 357 TABLE 377 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS 358 TABLE 378 ABBOTT LABORATORIES: DEALS 360 TABLE 379 DEXCOM, INC.: COMPANY OVERVIEW 362 TABLE 380 DEXCOM, INC.: PRODUCTS OFFERED 363 TABLE 381 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS 364 TABLE 382 DEXCOM, INC.: DEALS 364 TABLE 383 GE HEALTHCARE: COMPANY OVERVIEW 366 TABLE 384 GE HEALTHCARE: PRODUCTS OFFERED 367 TABLE 385 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS 369 TABLE 386 GE HEALTHCARE: DEALS 369 TABLE 387 PHILIPS HEALTHCARE: COMPANY OVERVIEW 371 TABLE 388 PHILIPS HEALTHCARE: PRODUCTS OFFERED 372 TABLE 389 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS 375 TABLE 390 PHILIPS HEALTHCARE: DEALS 375 TABLE 391 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 378 TABLE 392 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 379 TABLE 393 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS 381 TABLE 394 NIHON KOHDEN CORPORATION: DEALS 381 TABLE 395 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY OVERVIEW 383 TABLE 396 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCTS OFFERED 384 TABLE 397 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCT LAUNCHES & APPROVALS 385 TABLE 398 MINDRAY MEDICAL INTERNATIONAL LTD.: DEALS 386 TABLE 399 BD: COMPANY OVERVIEW 387 TABLE 400 BD: PRODUCTS OFFERED 388 TABLE 401 GETINGE AB: COMPANY OVERVIEW 390 TABLE 402 GETINGE AB: PRODUCTS OFFERED 391 TABLE 403 GETTING AB: PRODUCT ENHANCEMENTS, AND APPROVALS 392 TABLE 404 GETTING AB: DEALS 393 TABLE 405 BAXTER INTERNATIONAL: COMPANY OVERVIEW 394 TABLE 406 BAXTER INTERNATIONAL: PRODUCTS OFFERED 395 TABLE 407 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 398 TABLE 408 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 399 TABLE 409 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 402 TABLE 410 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 403 TABLE 411 BOSTON SCIENTIFIC CORPORATION: DEALS 404 TABLE 412 MASIMO CORPORATION: COMPANY OVERVIEW 405 TABLE 413 MASIMO CORPORATION: PRODUCTS OFFERED 406 TABLE 414 OMRON CORPORATION: COMPANY OVERVIEW 410 TABLE 415 OMRON CORPORATION: PRODUCTS OFFERED 411 TABLE 416 ARCHIMED SAS: BUSINESS OVERVIEW 415 TABLE 417 ARCHIMED SAS (NATUS MEDICAL): PRODUCTS OFFERED 415 TABLE 418 ARCHIMED SAS (NATUS MEDICAL): DEALS 416 TABLE 419 COMPUMEDICS LIMITED: BUSINESS OVERVIEW 417 TABLE 420 COMPUMEDICS LIMITED: PRODUCTS OFFERED 418 TABLE 421 COMPUMEDICS LIMITED: DEALS 419 TABLE 422 NONIN MEDICAL, INC.: BUSINESS OVERVIEW 420 TABLE 423 NONIN MEDICAL, INC.: PRODUCTS OFFERED 420 TABLE 424 NONIN MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS 421 TABLE 425 RISK ASSESSMENT: PATIENT MONITORING DEVICES 443 FIGURE 1 PATIENT MONITORING DEVICES MARKET SEGMENTATION 37 FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 41 FIGURE 3 PATIENT MONITORING DEVICES MARKET, 2026–2031 42 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT MONITORING DEVICES MARKET 43 FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PATIENT MONITORING DEVICES MARKET 44 FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PATIENT MONITORING DEVICES MARKET, 2026 45 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 46 FIGURE 8 STRINGENT REGULATORY FRAMEWORK IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH 47 FIGURE 9 HOSPITAL & CLINICS FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025 48 FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2026 TO 2031 49 FIGURE 11 NORTH AMERICA TO HOLD LARGEST MARKET SHARE TILL 2031 50 FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE 50 FIGURE 13 PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 14 PATIENT MONITORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 65 FIGURE 15 PATIENT MONITORING MARKET: SUPPLY CHAIN ANALYSIS 69 FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 71 FIGURE 17 PATIENT MONITORING DEVICES MARKET: ECOSYSTEM ANALYSIS 72 FIGURE 18 PATIENT MONITORING DEVICES MARKET: TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES 78 FIGURE 19 PATIENT MONITORING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO 79 FIGURE 20 NUMBER OF PATENTS PUBLISHED (JANUARY 2016–JUNE 2026) 89 FIGURE 21 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT MONITORING DEVICES (JANUARY 2016− JUNE 2026) 90 FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES 101 FIGURE 23 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES 101 FIGURE 24 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT 183 FIGURE 25 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT 247 FIGURE 26 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT MONITORING DEVICES MARKET, 2021–2025 (USD MILLION) 330 FIGURE 27 BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE ANALYSIS, 2025 331 FIGURE 28 CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS, 2025 331 FIGURE 29 MULTIPARAMETER MONITORING DEVICES MARKET SHARE ANALYSIS, 2023 332 FIGURE 30 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE ANALYSIS, 2025 332 FIGURE 31 FETAL & NEONATAL MONITORING DEVICES MARKET SHARE ANALYSIS, 2025 333 FIGURE 32 PATIENT MONITORING DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 336 FIGURE 33 PATIENT MONITORING DEVICES MARKET: COMPANY FOOTPRINT 337 FIGURE 34 PATIENT MONITORING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 342 FIGURE 35 EV/EBITDA OF KEY VENDORS 345 FIGURE 36 5-YEAR STOCK BETA OF KEY VENDORS 345 FIGURE 37 PATIENT MONITORING DEVICES MARKET: BRAND/PRODUCT COMPARISON 346 FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT 350 FIGURE 39 ABBOTT LABORATORIES: COMPANY SNAPSHOT 357 FIGURE 40 DEXCOM, INC.: COMPANY SNAPSHOT 362 FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT 367 FIGURE 42 PHILIPS HEALTHCARE: COMPANY SNAPSHOT 372 FIGURE 43 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 379 FIGURE 44 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY SNAPSHOT 383 FIGURE 45 BD: COMPANY SNAPSHOT 388 FIGURE 46 GETINGE AB.: COMPANY SNAPSHOT 391 FIGURE 47 BAXTER INTERNATIONAL: COMPANY SNAPSHOT 395 FIGURE 48 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT 399 FIGURE 49 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 403 FIGURE 50 MASIMO CORPORATION: COMPANY SNAPSHOT (2023) 406 FIGURE 51 OMRON CORPORATION: COMPANY SNAPSHOT 411 FIGURE 52 COMPUMEDICS LIMITED: COMPANY SNAPSHOT 417 FIGURE 53 RESEARCH DESIGN 430 FIGURE 54 PRIMARY SOURCES 433 FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS 435 FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION 435 FIGURE 57 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 436 FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC 437 FIGURE 59 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2025) 438 FIGURE 60 PATIENT MONITORING DEVICES MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2031) 440 FIGURE 61 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 440 FIGURE 62 DATA TRIANGULATION METHODOLOGY 441

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們